Thermo Fisher Scientific Debuts Pharmacogenetic Test to Improve Transplant Safety
Proper dosing helps prevent potential side effects such as developing diabetes and kidney damage
Emerging Tests-dtet
GRAIL’s Moves with MCED Test Illustrate Direct-to-Consumer Surge
By partnering with Hims & Hers and Epic, GRAIL bypasses traditional lab test arrangement
Quest Introduces Myeloma Test That Eliminates the Need for Bone Marrow Biopsies
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
Inflammatory Markers May Diagnose Back Conditions
...
Already a member? Log in here
NGS-Based Test for CF Promises Faster, Cheaper, More Thorough Analysis
...
Already a member? Log in here
More Than 1/4 of FDA’s 2015 Drug Approvals for Targeted Therapies
From - Diagnostic Testing & Emerging Technologies
More than 28 percent of the novel new drugs approved by U.S. Food and Drug Administration (FDA) in 2015 were…
New Molecular Test for Cystic Fibrosis Promises Faster, Better, Cheaper Analysis
From - Diagnostic Testing & Emerging Technologies
The future of cystic fibrosis (CF) diagnosis is in sight. Testing for the genetic disease helped to fuel the first wave of clinical molecular diagnostics, and now an assay developed by…
Paper-Based Test May Increase Male Fertility Self-Testing
...
Already a member? Log in here
Cost Effectiveness of Nail Fungus Confirmatory Test Treatment-Specific
...
Already a member? Log in here
Rise in Lyme Cases Drives Interest in New Tests
...
Already a member? Log in here